Best Antidepressant for Depression with Hearing Loss, Bruxism, and Tinnitus
For a patient with depression, hearing loss, bruxism, and tinnitus, nortriptyline is the optimal choice, as it has demonstrated efficacy in treating both depression and tinnitus-related distress while avoiding the bruxism-exacerbating effects of SSRIs.
Primary Recommendation: Nortriptyline
- Nortriptyline specifically addresses multiple comorbidities in this clinical scenario 1
- In depressed tinnitus patients, nortriptyline reduced depression severity by 65% and decreased tinnitus loudness by 10 dB (50%) with significant improvements in tinnitus severity and psychosocial dysfunction 1
- As a secondary-amine tricyclic antidepressant (TCA), nortriptyline has lower anticholinergic effects compared to tertiary-amine TCAs, making it safer with fewer adverse effects 2
- Nortriptyline combined with topiramate showed significant reduction in Tinnitus Functional Index scores from 58.4 to 46.3 in recent trials 3
Why Avoid SSRIs in This Patient
- SSRIs are contraindicated as first-line therapy because they induce or worsen bruxism 4
- The mechanism involves serotonergic effects that trigger teeth-grinding, which would directly exacerbate this patient's existing bruxism 4
- While fluoxetine and fluvoxamine may protect against cisplatin-induced ototoxicity 5, this benefit does not apply to patients with pre-existing hearing loss and tinnitus from other causes
- Paroxetine combined with verapamil showed efficacy for tinnitus (TFI score reduction from 54.6 to 42.2) 3, but the bruxism risk makes SSRIs problematic for this specific patient
Alternative Options if Nortriptyline Fails
- Bupropion is a reasonable second choice, as it does not cause bruxism and has favorable adverse effect profiles 2
- Mirtazapine offers faster onset of action compared to other antidepressants and does not typically worsen bruxism 6, 2
- Venlafaxine (SNRI) may be considered, though evidence regarding bruxism risk with SNRIs remains inconclusive 4
Clinical Context and Dosing
- Start nortriptyline at 25-150 mg daily (outpatient dosing range) 2
- Dose adjustment is needed in hepatic disease but not renal disease 2
- The high comorbidity between tinnitus, hearing loss, and depression (with tinnitus being more salient than hearing loss in predicting depression) 7, 8 makes addressing all conditions simultaneously critical
- 96% of chronic tinnitus patients endorse at least one psychiatric symptom, with internalizing psychopathology being the primary predictor of tinnitus-related distress 8
Common Pitfalls to Avoid
- Do not reflexively prescribe SSRIs as first-line therapy despite guideline recommendations for general depression, because the bruxism comorbidity changes the risk-benefit calculation 4
- If an SSRI has already been started and bruxism worsens, dopamine agonists or buspirone are the most effective medications to treat SSRI-induced bruxism 4
- Recognize that 52% of tinnitus patients have no identifiable hearing loss, indicating the psychological substrate is often primary rather than secondary to auditory damage 8